Message #2 From:
Stock News Bot Date: March 2, 2007 08:23:00 AM
FMS News Fresenius Medical Care Publishes Form 20-F for the Fiscal Year 2006
BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Medical Care (NYSE:FMS) (FWB:FME), the world’s leading renal therapy company, today announced that it has filed the annual report 2006 under Form 20-F with the U.S. Securities and Exchange Commission (SEC).
The report is available at the SEC's website, www.sec.gov, as well as at the Company’s web site in the “Investor Relations” section: http://www.fmc-ag.com/internet/fmc/fmcag/agintpub.nsf/Content/ SEC-Filings. (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)
A hard copy of Fresenius Medical Care’s annual report on Form 20-F including the complete audited financial statements may be obtained from the Company free of charge upon request to the Company's Investor Relations department by email at ir@fmc-ag.com
Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects about 1,500,000 individuals worldwide. Through its network of 2,108 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 163,517 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS-p).
For more information about Fresenius Medical Care visit the Company’s website at www.fmc-ag.com.
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.
